Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the red biotechnology market grown over the years?
The size of the red biotechnology market has experienced accelerated growth in recent years. The forecasts predict a rise from $566.28 billion in 2024 to $631.45 billion in 2025, signifying a compound annual growth rate (CAGR) of 11.5%. The expansion during the historical period can be traced back to progress in genetic engineering, stem cell studies, the emergence of biotech startups, the implementation of regulatory frameworks, funding of biotech initiatives, and investments.
What Is the forecasted market size and growth rate for the red biotechnology market?
The red biotechnology market size is expected to see rapid growth in the next few years. It will grow to $963.55 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to the expansion of personalized medicine, the aging population, investment in research and development, digital health integration, and the expansion of healthcare infrastructure. Major trends in the forecast period include the expansion of biologics and biosimilars, integration of machine learning, development of microbiome-based therapies, focus on rare and orphan diseases, global collaboration, and partnerships.
Get your red biotechnology market report here!
https://www.thebusinessresearchcompany.com/report/red-biotechnology-global-market-report
What are the major factors driving growth in the red biotechnology market?
The rise in the need for bespoke healthcare services is projected to fuel the expansion of the red biotechnology market. Bespoke medical care involves customizing medical procedures to match personal attributes like genetic information or lifestyle patterns, enabling highly effective treatments with minimal adverse reactions. This surge in demand for bespoke healthcare is primarily due to its ability to offer superior therapeutic options, alongside advancements in genomics, more complex diseases, and regulatory backing. Red biotechnology facilitates the production of these precision medicines, using genetic data to create treatments specifically aimed at the genetic profile and disease characteristics of each patient. For example, the Personalized Medicine Coalition, a not-for-profit entity based in the US, reported that the FDA sanctioned 16 unique customized therapies for patients with rare illnesses in 2023, a significant increase from only six the previous year. Hence, this rising need for customized healthcare services fuels the expansion of the red biotechnology market.
What key areas define the segmentation of the global red biotechnology Market?
The red biotechnology market covered in this report is segmented –
1) By Product: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Proteins, Vaccines, Cell-Based Immunotherapy Products, Gene Therapy Products, Cell Therapy Products, Tissue-Engineered Products, Other Products
2) By Application: Drug Discovery And Development, Animal Biotechnology, Environmental Biotechnology, Medical Biotechnology, Industrial Biotechnology, Agricultural Biotechnology, Other Applications
3) By End-User: Biopharmaceutical Industry, Contract Manufacturing Organization (CMO) And Contract Research Organization (CRO) Research Institutes, Other End Users
Subsegments:
1) By Monoclonal Antibodies: Therapeutic Monoclonal Antibodies, Diagnostic Monoclonal Antibodies, Biosimilars Of Monoclonal Antibodies, Targeted Monoclonal Antibodies (For Cancer, Autoimmune Diseases)
2) By Polyclonal Antibodies: Diagnostic Polyclonal Antibodies, Therapeutic Polyclonal Antibodies, Veterinary Polyclonal Antibodies, Research Polyclonal Antibodies
3) By Recombinant Proteins: Enzyme Replacement Therapies, Growth Factors And Hormones, Clotting Factor Products, Interferons And Cytokines
4) By Vaccines: Preventive Vaccines (For Influenza, Covid-19, Hpv), Therapeutic Vaccines (Cancer Vaccines), Dna Or Rna-Based Vaccines, Protein Subunit Vaccines
5) By Cell-Based Immunotherapy Products: Car-T-Cell Therapies, T-Cell Receptor Therapies, Nk Cell Therapies, Dendritic Cell-Based Immunotherapies
6) By Gene Therapy Products: Gene Editing (Crispr-Based Therapies), Viral Vector-Based Gene Therapies, Gene Silencing Therapies, In Vivo Gene Therapy Products
7) By Cell Therapy Products: Stem Cell Therapies, Regenerative Cell Therapies (Mesenchymal Stem Cells), Autologous Cell Therapies, Allogeneic Cell Therapies
8) By Tissue-Engineered Products: Skin And Cartilage Engineered Products, Bone And Muscle Regenerative Products, Cardiovascular Tissue Engineering, Neural Tissue Engineering
9) By Other Products: Blood And Blood Components (E.g., Blood Substitutes), Protein Therapeutics, Diagnostic Kits And Tools (Biomarkers, Assays), Regenerative Medicine Products
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16173&type=smp
What are the top market players propelling the growth of the red biotechnology industry?
Major companies operating in the red biotechnology market are Pfizer Inc., F. Hoffmann-La Roche AG, Bayer AG, Bristol-Myers Squibb Company, GSK plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences, Amgen Inc., Merck KGaA, Moderna Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Boehringer Ingelheim International GmbH, BioMarin Pharmaceutical Inc., Vir Biotechnology, Alnylam Pharmaceuticals, Inc., Ultragenyx Pharmaceutical, BioCryst Pharmaceuticals, Sangamo Therapeutics, Inc., Denali Therapeutics, Atara Biotherapeutics, Beam Therapeutics, Umoja Biopharma
What are the key trends shaping the future of the red biotechnology market?
Key players in the red biotechnology market are prioritizing the creation of innovative products such as biosimilars, in order to cater to the rising need for personalized medicine and address the complexity of diseases. Biosimilars, which are biologic products very similar to an approved reference biologic, provide more cost-effective alternatives. For example, in June 2022, the U.S. biopharmaceutical firm, Amgen Inc., secured approval from the U.S. Food and Drug Administration (FDA) for Riabni (rituximab-arrx), a biosimilar to Rituxan (rituximab), intended for the treatment of adults suffering from moderate to severe rheumatoid arthritis (RA). This approval represents a significant achievement in the advancement of biosimilars, intended to mirror existing biological products but at a reduced price.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16173
Which geographic areas are influencing the growth of the red biotechnology market?
North America was the largest region in the red biotechnology market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the red biotechnology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Agricultural Biotechnology Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/agricultural-biotechnology-global-market-report
Biotechnology Reagents Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/biotechnology-reagents-global-market-report
Biotechnology Services Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/biotechnology-services-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
